Abstract

Hypo-responsiveness to controlled ovarian stimulation is an undervalued topic in reproductive medicine. This phenomenon manifests as a low follicles output rate (FORT) with a discrepancy between the relatively low number of pre-ovulatory follicles which develop following ovarian stimulation as compared to the number of antral follicles available at the start of stimulation. The pathophysiology mechanisms explaining the ovarian resistance to gonadotropin stimulation are not fully understood, but the fact that both hypo-responders and normal responders share similar phenotypic characteristics suggests a genotype-based mechanism. Indeed, existing evidence supports the association between specific gonadotropin and their receptor polymorphisms and ovarian hypo-response. Apart from genotypic trait, environmental contaminants and oxidative stress might also be involved in the hypo-response pathogenesis. The ratio between the number of oocytes collected at the ovum pick up and the number of antral follicles at the beginning of OS [Follicle to oocyte index (FOI)] is proposed as a novel parameter to assess the hypo-response. Compared with traditional ovarian reserve markers, FOI might reflect most optimally the dynamic nature of follicular growth in response to exogenous gonadotropin. In this review, we contextualize the role of FOI as a parameter to identify this condition, discuss the underlying mechanisms potentially implicated in the pathogenesis of hypo-response, and appraise possible the treatment strategies to overcome hyper-responsiveness to gonadotropin stimulation.

Highlights

  • Ovarian stimulation (OS) is an essential step in assisted reproductive technology (ART)

  • We propose an alternative approach to address the ovarian resistance to gonadotropin stimulation based on the concept of follicles output rate (FORT), namely, the ratio between the total number of oocytes collected at the end of OS, and the number of antral follicles available at the start of stimulation (Follicleto-Oocyte Index [follicle-to-oocyte index (FOI)]) (Figures 2, 3)

  • Until genotyping testing becomes widely available, other indices such as the FORT and FOI can be used as surrogate measures to identify women with ovarian resistance to gonadotropin stimulation

Read more

Summary

Introduction

Ovarian stimulation (OS) is an essential step in assisted reproductive technology (ART). We [1] illustrate how to identify patients with ovarian resistance to exogenous gonadotropins who undergo ART by use of a new marker named follicle-to-oocyte index (FOI), [2] discuss the underlying pathogenetic mechanisms associated with hypo-response, and lastly, [3] critically appraise possible treatment strategies to overcome this condition.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call